Kim JH - Search Results

1

Korean Practice Guidelines for Gastric Cancer 2022: An Evidence-based, Multidisciplinary Approach.

Kim TH, Kim IH, Kang SJ, Choi M, Kim BH, Eom BW, Kim BJ, Min BH, Choi CI, Shin CM, Tae CH, Gong CS, Kim DJ, Cho AE, Gong EJ, Song GJ, Im HS, Ahn HS, Lim H, Kim HD, Kim JJ, Yu JI, Lee JW, Park JY, Kim JH, Song KD, Jung M, Jung MR, Son SY, Park SH, Kim SJ, Lee SH, Kim TY, Bae WK, Koom WS, Jee Y, Kim YM, Kwak Y, Park YS, Han HS, Nam SY, Kong SH; Development Working Groups for the Korean Practice Guidelines for Gastric Cancer 2022 Task Force Team. Kim TH, et al. Among authors: kim ih, kim jj, kim ym, kim ty, kim bh, kim dj, kim sj, kim bj, kim hd, kim jh. J Gastric Cancer. 2023 Jan;23(1):3-106. doi: 10.5230/jgc.2023.23.e11. J Gastric Cancer. 2023. PMID: 36750993 Free PMC article. Review.

2

Rivaroxaban Versus Low-molecular-weight Heparin for Venous Thromboembolism in Advanced Upper Gastrointestinal Tract and Hepatopancreatobiliary Cancer.

Kim JH, Seo S, Kim KP, Chang HM, Ryoo BY, Yoo C, Jeong JH, Lee JL, Im HS, Jeong H, Bang Y, Park SR. Kim JH, et al. Among authors: kim kp. In Vivo. 2020 Mar-Apr;34(2):829-837. doi: 10.21873/invivo.11845. In Vivo. 2020. PMID: 32111791 Free PMC article.

3

Use of Gemcitabine plus Carboplatin is Associated with Poor Outcomes in Urothelial Carcinoma Patients with Chronic Kidney Disease Stage 4-5.

Kim HD, Im HS, Kim JH, Jeong H, Yoon SK, Park I, Lee JL. Kim HD, et al. Among authors: kim jh. Cancer Res Treat. 2021 Oct;53(4):1166-1173. doi: 10.4143/crt.2021.091. Epub 2021 Mar 4. Cancer Res Treat. 2021. PMID: 33677847 Free PMC article.

4

The Prognosis and the Role of Adjuvant Chemotherapy for Node-Positive Bladder Cancer Treated with Neoadjuvant Chemotherapy Followed by Surgery.

Jeong H, Park KJ, Lee Y, Kim HD, Kim JH, Yoon S, Hong B, Lee JL. Jeong H, et al. Among authors: kim hd, kim jh. Cancer Res Treat. 2022 Jan;54(1):226-233. doi: 10.4143/crt.2021.365. Epub 2021 May 6. Cancer Res Treat. 2022. PMID: 33957019 Free PMC article.

5

Clinical implications of the tumor microenvironment using multiplexed immunohistochemistry in patients with advanced or metastatic renal cell carcinoma treated with nivolumab plus ipilimumab.

Kim JH, Kim GH, Ryu YM, Kim SY, Kim HD, Yoon SK, Cho YM, Lee JL. Kim JH, et al. Among authors: kim gh, kim sy, kim hd. Front Oncol. 2022 Sep 27;12:969569. doi: 10.3389/fonc.2022.969569. eCollection 2022. Front Oncol. 2022. PMID: 36237314 Free PMC article.

6

Erratum: Korean Practice Guidelines for Gastric Cancer 2022: An Evidence-based, Multidisciplinary Approach.

Kim TH, Kim IH, Kang SJ, Choi M, Kim BH, Eom BW, Kim BJ, Min BH, Choi CI, Shin CM, Tae CH, Gong CS, Kim DJ, Cho AE, Gong EJ, Song GJ, Im HS, Ahn HS, Lim H, Kim HD, Kim JJ, Yu JI, Lee JW, Park JY, Kim JH, Song KD, Jung M, Jung MR, Son SY, Park SH, Kim SJ, Lee SH, Kim TY, Bae WK, Koom WS, Jee Y, Kim YM, Kwak Y, Park YS, Han HS, Nam SY, Kong SH. Kim TH, et al. Among authors: kim ih, kim jj, kim ym, kim ty, kim bh, kim dj, kim sj, kim bj, kim hd, kim jh. J Gastric Cancer. 2023 Apr;23(2):365-373. doi: 10.5230/jgc.2023.23.e20. J Gastric Cancer. 2023. PMID: 37129159 Free PMC article.

7

Real-world outcomes of third-line immune checkpoint inhibitors versus irinotecan-based chemotherapy in patients with advanced gastric cancer: a Korean, multicenter study (KCSG ST22-06).

Lim SH, Lee KW, Kim JJ, Im HS, Kim IH, Han HS, Koo DH, Cho JH, Maeng CH, Lee MY, Lee HJ, Kim JH, Park SG, Jung JY, Shin SH, Kim KH, Kim H, Oh SY, Kang M, Jung M, Rha SY. Lim SH, et al. Among authors: kim ih, kim jj, kim h, kim kh, kim jh. BMC Cancer. 2024 Feb 23;24(1):252. doi: 10.1186/s12885-024-11972-w. BMC Cancer. 2024. PMID: 38395832 Free PMC article.

8

Korean Practice Guidelines for Gastric Cancer 2024: An Evidence-based, Multidisciplinary Approach (Update of 2022 Guideline).

Kim IH, Kang SJ, Choi W, Seo AN, Eom BW, Kang B, Kim BJ, Min BH, Tae CH, Choi CI, Lee CK, An HJ, Byun HK, Im HS, Kim HD, Cho JH, Pak K, Kim JJ, Bae JS, Yu JI, Lee JW, Choi J, Kim JH, Choi M, Jung MR, Seo N, Eom SS, Ahn S, Kim SJ, Lee SH, Lim SH, Kim TH, Han HS; Development Working Group for the Korean Practice Guideline for Gastric Cancer 2024 Task Force Team. Kim IH, et al. Among authors: kim jj, kim th, kim sj, kim bj, kim hd, kim jh. J Gastric Cancer. 2025 Jan;25(1):5-114. doi: 10.5230/jgc.2025.25.e11. J Gastric Cancer. 2025. PMID: 39822170 Free PMC article. Review.

9

Spatial Distribution and Prognostic Implications of Tumor-Infiltrating FoxP3- CD4+ T Cells in Biliary Tract Cancer.

Kim HD, Kim JH, Ryu YM, Kim D, Lee S, Shin J, Hong SM, Kim KH, Jung DH, Song GW, Hwang DW, Lee JH, Song KB, Ryoo BY, Jeong JH, Kim KP, Kim SY, Yoo C. Kim HD, et al. Among authors: kim d, kim kp, kim sy, kim kh, kim jh. Cancer Res Treat. 2021 Jan;53(1):162-171. doi: 10.4143/crt.2020.704. Epub 2020 Aug 31. Cancer Res Treat. 2021. PMID: 32878426 Free PMC article.

10

Real-world utility of next-generation sequencing for targeted gene analysis and its application to treatment in lung adenocarcinoma.

Kim JH, Yoon S, Lee DH, Jang SJ, Chun SM, Kim SW. Kim JH, et al. Among authors: kim sw. Cancer Med. 2021 May;10(10):3197-3204. doi: 10.1002/cam4.3874. Epub 2021 May 7. Cancer Med. 2021. PMID: 33960703 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

32,409 results

Search Page

Filters